{
    "id": 16293,
    "fullName": "FBXW7 mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "FBXW7 mutant indicates an unspecified mutation in the FBXW7 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 55294,
        "geneSymbol": "FBXW7",
        "terms": [
            "FBXW7",
            "AGO",
            "CDC4",
            "FBW6",
            "FBW7",
            "FBX30",
            "FBXO30",
            "FBXW6",
            "hAgo",
            "hCdc4",
            "SEL-10",
            "SEL10"
        ]
    },
    "variant": "mutant",
    "createDate": "01/11/2016",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15183,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, LY3039478 treatment resulted in partial response lasted 9.5 months in a patient with hormone receptor-positive, Erbb2 (Her2)-negative breast cancer harboring FBXW7 mutation (PMID: 30060061; NCT01695005).",
            "molecularProfile": {
                "id": 16574,
                "profileName": "FBXW7 mutant"
            },
            "therapy": {
                "id": 2958,
                "therapyName": "LY3039478",
                "synonyms": null
            },
            "indication": {
                "id": 60080,
                "name": "Her2-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12806,
                    "pubMedId": 30060061,
                    "title": "First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30060061"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 16574,
            "profileName": "FBXW7 mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}